The gene business. Who should control biotechnology

Book · Sun Jan 01 04:00:00 EST 1984

OSTI ID:6044442

Yoxen, E

This book discusses about the big business of genetic engineering. The author argues that the questions raised by biotechnology should be decided on ethical grounds and in terms of the public good; whereas the corporations that have sprung up to manufacture and market these man-made organisms will decide them solely in terms of profit. He examines affected (and threatened) areas such as agriculture (new crops, animal breeding); chemistry (new fuels); and pharmacology (interferon, artificial insulin); naming names and including the corporations, drug companies and scientists engaged in this enterprise, no less revolutionary than nuclear power.

• OSTI ID: 6044442
• Country of Publication: United States
• Language: English

Related Subjects

09 BIOMASS FUELS
140504 -- Solar Energy Conversion-- Biomass Production & Conversion-- (-1989)
29 ENERGY PLANNING, POLICY, AND ECONOMY
290200* -- Energy Planning & Policy-- Economics & Sociology
290500 -- Energy Planning & Policy-- Research
Development
Demonstration
& Commercialization
550200 -- Biochemistry
550400 -- Genetics
59 BASIC BIOLOGICAL SCIENCES
ANIMAL BREEDING
BACTERIA
BIOSYNTHESIS
BIOTECHNOLOGY
CHEMISTRY
COMMERCIALIZATION
CONTROL
COST
COST OVERRUNS
CROPS
DRUGS
ECONOMIC IMPACT
ECONOMICS
ETHICAL ASPECTS
FUELS
GENE AMPLIFICATION
GENE REGULATION
GENES
GENETIC CONTROL
HORMONES
INSULIN
MAN-MACHINE SYSTEMS
MANUFACTURERS
MARKETING RESEARCH
MICROORGANISMS
NUCLEAR POWER
PEPTIDE HORMONES
PEST CONTROL
PHARMACOLOGY
POWER
SUPPLY AND DEMAND
SYNTHESIS